Recombinant GD2 (Naxitamab Biosimilar) antibody
The Humanized Chimeric anti-GD2 (Naxitamab Biosimilar) antibody (ABIN7538080) specifically detects GD2 (Naxitamab Biosimilar) in ELISA and WB.
The antibody is reactive with Human samples.
Catalog No. ABIN7538080
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant GD2 (Naxitamab Biosimilar) antibody (ABIN7538080)
Target
GD2 (Naxitamab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This GD2 (Naxitamab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Naxitamab Biosimilar – Anti-GD2 mAb - Research Grade
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- GD2 (Naxitamab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers.
-
CAS-No
- 1879925-92-4
Target
-
You are here:
